{"protocolSection": {"identificationModule": {"nctId": "NCT01441583", "orgStudyIdInfo": {"id": "CR-CL-07202011-B-H"}, "organization": {"fullName": "Boston Scientific Corporation", "class": "INDUSTRY"}, "briefTitle": "Ingenio Device Algorithm Study", "officialTitle": "Ingenio Device Algorithm Study", "acronym": "IVORY"}, "statusModule": {"statusVerifiedDate": "2024-03", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2011-10"}, "primaryCompletionDateStruct": {"date": "2012-06", "type": "ACTUAL"}, "completionDateStruct": {"date": "2013-04", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-09-26", "studyFirstSubmitQcDate": "2011-09-26", "studyFirstPostDateStruct": {"date": "2011-09-27", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2021-04-23", "resultsFirstSubmitQcDate": "2024-03-18", "resultsFirstPostDateStruct": {"date": "2024-03-21", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2024-03-18", "lastUpdatePostDateStruct": {"date": "2024-03-21", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Boston Scientific Corporation", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The purpose of the IVORY Study is to gather data to support global submissions/approvals for some models of the Ingenio device family.", "detailedDescription": "IVORY is a prospective, multi-center, randomized within-patient, single-blinded study to gather data to support Right Atrial Auto Threshold and RYTHMIQ"}, "conditionsModule": {"conditions": ["Sinus Node Disease", "AV Block", "Heart Failure"], "keywords": ["pacemaker, CRT-P, auto threshold"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "CROSSOVER", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "SINGLE", "whoMasked": ["PARTICIPANT"]}}, "enrollmentInfo": {"count": 139, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Pacemaker - RYTHMIQ Off at Pre-discharge, On at 1-Month", "type": "ACTIVE_COMPARATOR", "description": "For the RYTHMIQ endpoint only, subjects implanted with a pacemaker will be randomized. Those randomized to RYTHMIQ Off at Pre-Discharge will have RYTHMIQ programmed Off until their 1-month follow up, when they will be crossed over to RYTHMIQ On until their 3-month follow up.", "interventionNames": ["Device: RAAT", "Device: RYTHMIQ"]}, {"label": "Pacemaker - RYTHMIQ On at Pre-Discharge, Off at 1-Month", "type": "ACTIVE_COMPARATOR", "description": "For the RYTHMIQ endpoint only, subjects implanted with a pacemaker will be randomized. Those randomized to RYTHMIQ On at Pre-Discharge will have RYTHMIQ programmed On until their 1-month follow up, when they will be crossed over to RYTHMIQ Off until their 3-month follow up.", "interventionNames": ["Device: RAAT", "Device: RYTHMIQ"]}, {"label": "CRT-P", "type": "EXPERIMENTAL", "description": "CRT-P devices were not involved in RYTHMIQ endpoint evaluation, only RAAT.", "interventionNames": ["Device: RAAT"]}], "interventions": [{"type": "DEVICE", "name": "RAAT", "description": "For Pacemaker and CRT-P: Right Atrial Automatic Threshold (RAAT)", "armGroupLabels": ["CRT-P", "Pacemaker - RYTHMIQ Off at Pre-discharge, On at 1-Month", "Pacemaker - RYTHMIQ On at Pre-Discharge, Off at 1-Month"]}, {"type": "DEVICE", "name": "RYTHMIQ", "description": "For pacemakers only: RYTHMIQ RYTHMIQ randomized to on at pre-discharge or at 1-month, depending on assignment", "armGroupLabels": ["Pacemaker - RYTHMIQ Off at Pre-discharge, On at 1-Month", "Pacemaker - RYTHMIQ On at Pre-Discharge, Off at 1-Month"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Accuracy of Commanded Right Atrial Automatic Threshold (RAAT)", "description": "Accuracy was evaluated by the proportion of tests resulting in an RAAT commanded threshold with \\|Manual unipolar threshold - commanded threshold\\| \u2264 0.5V. Subjects were allowed to contribute multiple paired datasets for this endpoint analysis, one set each from the 1-month and 3-month visits. Paired datasets from the 1-month and 3-month visits were pooled for purposes of endpoint analysis. A paired dataset consisted of the manual unipolar threshold and the commanded threshold obtained at a visit.", "timeFrame": "3 months post implant"}, {"measure": "System-related Complication-free Rate", "description": "Arms/Groups are only applicable for the outcome measure 'Secondary Outcome: RYTHMIQ - Median Relative Reduction of RV Pacing Percent (RVPP) for RYTHMIQ Programmed to ON vs. RYTHMIQ Programmed to OFF'.\n\nThis outcome measure was analyzed only for the combined population and both pacemakers and CRT-P devices were pooled for the analysis. The analysis assesses the system-related complication (SRC) -free rate (excluding LV related events for CRT-P subjects) for subjects implanted or attempted to be implanted with a study device through the first 90 days following the implant procedure.", "timeFrame": "90 days post-implant"}], "secondaryOutcomes": [{"measure": "Accuracy of Ambulatory RAAT", "description": "Arms/Groups are only applicable for the outcome measure 'Secondary Outcome: RYTHMIQ - Median Relative Reduction of RV Pacing Percent (RVPP) for RYTHMIQ Programmed to ON vs. RYTHMIQ Programmed to OFF'.\n\nThis outcome measure was analyzed only for the combined population (pacemaker and CRT-P). Accuracy was evaluated by the proportion of tests resulting in an RAAT ambulatory threshold with \\|ambulatory threshold - commanded threshold\\| \u2264 1.0V. Subjects were allowed to contribute multiple paired datasets for this endpoint analysis, one set each from the 1-month and 3-month visits. Paired datasets from the 1-month and 3-month visits were pooled for purposes of endpoint analysis. A paired dataset consisted consisted of the ambulatory threshold obtained within 7 days prior to the visit and the commanded threshold obtained at the visit.", "timeFrame": "3 months post-implant"}, {"measure": "Appropriate RAAT Test Outcome", "description": "Arms/Groups are only applicable for the outcome measure 'Secondary Outcome: RYTHMIQ - Median Relative Reduction of RV Pacing Percent (RVPP) for RYTHMIQ Programmed to ON vs. RYTHMIQ Programmed to OFF'.\n\nThis outcome measure was analyzed only for the combined population (pacemaker and CRT-P). Accuracy was evaluated by the proportion of tests with an appropriate commanded RAAT test outcome. An appropriate RAAT outcome consists of either a device-determined threshold or a code indicating that a threshold could not be determined and representing a condition that is beyond the control of the RAAT feature and could occur as well in manual threshold test, such as atrial fibrillation.", "timeFrame": "3 months post-implant"}, {"measure": "RYTHMIQ - Median Relative Reduction of RV Pacing Percent (RVPP) for RYTHMIQ On at Pre-Discharge, Off at 1-Month vs. RYTHMIQ Off at Pre-discharge, On at 1-Month", "description": "Chronic success is assessed by a median relative reduction of RV pacing percent (RVPP) for RYTHMIQ On at Pre-Discharge, Off at 1-Month vs. RYTHMIQ On at Pre-Discharge, Off at 1-Month. All patients received both RYTHMIQ programmed to ON and programmed to OFF in two consecutive periods, where the patient's programming allocation was randomized for the first period. Then a crossover to the alternate setting occurred for the second period once the end of the first period was reached.", "timeFrame": "3 months post implant"}, {"measure": "Percentage of RAAT Threshold Tests With Sufficient RAAT Pace Output Margin", "description": "This outcome measure was analyzed only for the combined population (Pacemaker and CRT-P). The sufficient pacing output voltage that is able to capture the right atrium was evaluated by the proportion of Right Atrial Automatic Threshold (RAAT) tests with \\[RAAToutput \u2265 (max(BP,UP) + \u03b4 )\\] where BP refers to the manual bipolar threshold, UP refers to the manual unipolar threshold, and \u03b4 refers to the safety margin of 0.5V. Subjects were allowed to contribute multiple paired datasets for this endpoint analysis, one set each from the 1-month and 3-month visits. Paired datasets from the 1-month and 3-month visits were pooled for purposes of endpoint analysis. A paired dataset consisted of the commanded threshold and the maximum manual threshold (i.e. the maximum of the manual unipolar and manual bipolar thresholds) obtained at a visit.", "timeFrame": "3 months post implant"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Subjects who are willing and capable of providing informed consent to undergo a device implant and to participate in all testing associated with this clinical study;\n* Subjects whose age is 18 or above, or of legal age to give informed consent specific to national law;\n* Subjects indicated for a dual chamber pacemaker or a CRT-P device according to class I or class II indications of the standard ESC or ACC / AHA implant guidelines;\n* Subjects who are planned to be implanted with all leads intended for a specific device type (dual chamber pacemaker: atrial and right ventricular lead, CRT-P: atrial, right and left ventricular lead) or are already implanted with such leads;\n* Subjects who receive or are implanted with a bipolar atrial lead.\n\nExclusion Criteria:\n\n* Women of childbearing potential who are or might be pregnant at the time of the study (method of assessment upon physician's discretion);\n* Enrolled in any other concurrent study, with the exception of local mandatory governmental registries and observational studies/registries that are not in conflict or affect\n* Schedule of procedures for IVORY (i.e. should not cause additional or missed visits);\n* Programming of devices for IVORY per CIP;\n* IVORY outcome (i.e. involve medications that could affect the heart rate of the subject);\n* Conduct of IVORY per GCP / ISO 14 155:2011 / local regulations.\n* Subjects who live at such a distance from the clinic that travels for FU visits at a study center would be unusually difficult or burdensome for the subject;\n* Inability or refusal to comply with the FU schedule;\n* A life expectancy of less than 12 months, per physician discretion;\n* Subjects who are planned to be programmed to a pacing mode other than DDD / DDDR during the study period.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Roy S Gardner, MD", "affiliation": "Golden Jubilee National Hospital", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Jens Goetzke, Dipl.-Ing. (FH)", "affiliation": "Boston Scientific Corporation", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Wilhelminenspital", "city": "Vienna", "zip": "1160", "country": "Austria", "geoPoint": {"lat": 48.20849, "lon": 16.37208}}, {"facility": "Landesklinikum Wiener Neustadt", "city": "Wiener Neustadt", "zip": "2700", "country": "Austria", "geoPoint": {"lat": 47.80484, "lon": 16.23201}}, {"facility": "Clinique Universitaires Saint Luc", "city": "Brussels", "zip": "1200", "country": "Belgium", "geoPoint": {"lat": 50.85045, "lon": 4.34878}}, {"facility": "Rigshospitalet Copenhagen", "city": "Copenhagen", "zip": "2100", "country": "Denmark", "geoPoint": {"lat": 55.67594, "lon": 12.56553}}, {"facility": "Gentofte University Hospital", "city": "Hellerup", "zip": "2900", "country": "Denmark", "geoPoint": {"lat": 55.73204, "lon": 12.57093}}, {"facility": "NCN Nouvelles Cliniques Nantaises", "city": "Nantes Cedex 2", "zip": "44277", "country": "France", "geoPoint": {"lat": 47.21725, "lon": -1.55336}}, {"facility": "Clinique Saint-Hilaire Rouen", "city": "Rouen", "zip": "7600", "country": "France", "geoPoint": {"lat": 49.44313, "lon": 1.09932}}, {"facility": "Krankenhaus Neu Bethlehem", "city": "G\u00f6ttingen", "zip": "37073", "country": "Germany", "geoPoint": {"lat": 51.53443, "lon": 9.93228}}, {"facility": "Heinrich Braun Krankenhaus", "city": "Zwickau", "zip": "08060", "country": "Germany", "geoPoint": {"lat": 50.72724, "lon": 12.48839}}, {"facility": "Prince of Wales Hospital", "city": "Shatin", "state": "New Territories", "country": "Hong Kong", "geoPoint": {"lat": 22.38333, "lon": 114.18333}}, {"facility": "Azienda Ospedaliera Mater Domini Policlinico Universitario", "city": "Catanzaro", "state": "CZ", "zip": "88100", "country": "Italy", "geoPoint": {"lat": 38.88247, "lon": 16.60086}}, {"facility": "Policlinico Casilino", "city": "Roma", "state": "RM", "zip": "00169", "country": "Italy", "geoPoint": {"lat": 41.89193, "lon": 12.51133}}, {"facility": "Institut Jantung Negara", "city": "Kuala Lumpur", "zip": "50400", "country": "Malaysia", "geoPoint": {"lat": 3.1412, "lon": 101.68653}}, {"facility": "Amphia Ziekenhuis", "city": "Breda", "zip": "4818 CK", "country": "Netherlands", "geoPoint": {"lat": 51.58656, "lon": 4.77596}}, {"facility": "Rijnland Ziekenhuis", "city": "Leiderdorp", "zip": "2353 GA", "country": "Netherlands", "geoPoint": {"lat": 52.15833, "lon": 4.52917}}, {"facility": "Hospital Clinico Y Provincial", "city": "Barcelona", "zip": "08036", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"facility": "Clinica Universitaria de Navarra", "city": "Pamplona", "zip": "31008", "country": "Spain", "geoPoint": {"lat": 42.81687, "lon": -1.64323}}, {"facility": "Sahlgrenska University Hospital", "city": "G\u00f6teborg", "zip": "41345", "country": "Sweden", "geoPoint": {"lat": 57.70716, "lon": 11.96679}}, {"facility": "Karolinska Hospital", "city": "Stockholm", "zip": "17176", "country": "Sweden", "geoPoint": {"lat": 59.33258, "lon": 18.0649}}, {"facility": "Golden Jubilee National Hospital", "city": "Clydebank", "zip": "G81 4HX", "country": "United Kingdom", "geoPoint": {"lat": 55.90137, "lon": -4.4057}}, {"facility": "Northern General Hospital", "city": "Sheffield", "zip": "S5 7AU", "country": "United Kingdom", "geoPoint": {"lat": 53.38297, "lon": -1.4659}}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Of 139 subjects, 132 were implanted with a study device. Of those subjects who were not implanted with a study device 4 signed informed consent, met eligibility criteria and had anesthesia administered in preparation for the surgical procedure but did not receive a study device (classified as 'Attempt') and 3 signed the informed consent, met eligibility criteria but did not undergo an implant (classified as an 'Intent').", "recruitmentDetails": "Subjects were recruited from the general patient population indicated for a dual chamber pacemaker or cardiac resynchronization therapy pacemaker implantation at 15 study centers. First enrollment date was in October 2011 and the last subject was enrolled in March 2012.", "groups": [{"id": "FG000", "title": "RYTHMIQ Off at Pre-discharge, On at 1-Month", "description": "Pacemaker - RYTHMIQ Off at Pre-discharge, On at 1-Month"}, {"id": "FG001", "title": "RYTHMIQ On at Pre-Discharge, Off at 1-Month", "description": "Pacemaker -RYTHMIQ On at Pre-Discharge, Off at 1-Month"}, {"id": "FG002", "title": "CRT-P", "description": "All CRT-P implanted subjects"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "50"}, {"groupId": "FG001", "numSubjects": "50"}, {"groupId": "FG002", "numSubjects": "36"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "48"}, {"groupId": "FG001", "numSubjects": "49"}, {"groupId": "FG002", "numSubjects": "27"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "9"}]}], "dropWithdraws": [{"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "4"}]}, {"type": "Underwent anaesthesia, but not finally implanted", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "4"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Baseline Analysis Population includes all implanted subjects (n=132) as well as 4 attempted CRT-P subjects that could not be successfully implanted but underwent anesthesia. Total baseline population is therefore n=136.", "groups": [{"id": "BG000", "title": "Pacemaker", "description": "Subjects receiving a pacemaker study device (implanted or attempted)"}, {"id": "BG001", "title": "CRT-P", "description": "Subjects receiving a CRT-P study device (implanted or attempted)"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "73.3", "spread": "10.9"}, {"groupId": "BG001", "value": "72.7", "spread": "9.5"}, {"groupId": "BG002", "value": "73.2", "spread": "10.5"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "60"}, {"groupId": "BG001", "value": "28"}, {"groupId": "BG002", "value": "88"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "40"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "48"}]}]}]}, {"title": "Pacemaker Indication", "description": "Not applicable for CRT-P device category", "populationDescription": "Pacemaker indications are not applicable for CRT-P device category, hence it was not analyzed.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "AV Block", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "100"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "56"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "56"}]}]}, {"title": "Sinus Node Dysfunction", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "100"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "37"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "37"}]}]}, {"title": "Other Block (i.e. Chronic Bifascicular Block)", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "100"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "5"}]}]}, {"title": "Hypersensitive Carotid Sinus Syndrome", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "100"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}]}, {"title": "Brady-Tachy Syndrome", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "100"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}]}]}, {"title": "CRT-P Indication", "description": "Class I indication (ind.) for CRT-P device, defined by Left Ventricular Ejection Fraction (EF) = \u2264 35%, sinus rhythm, NYHA Class III, or ambulatory NYHA Class IV, QRS width (QRS) of \u2265 120 ms and optimal heart failure drug therapy (OPT). Recommended ind.\n\nClass IIa, defined by EF \u2264 35%, NYHA Class III, or ambulatory NYHA Class IV, OPT, frequent dependence on ventricular pacing. Ind. should be considered.\n\nClass IIb, defined by EF \u2264 35%, NYHA Class I or II, OPT, device implant with anticipated frequent ventricular pacing. Ind. can be considered.\n\nNot applicable for pacemaker device category.", "populationDescription": "CRT-P indications are not applicable for pacemaker device category, hence it was not analyzed.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Class I - EF \u2264 35%, sinus rhythm, NYHA Class III, or ambulatory NYHA Class IV, QRS \u2265 120 ms, OPT", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "36"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "19"}, {"groupId": "BG002", "value": "19"}]}]}, {"title": "Class IIa - EF \u2264 35%, NYHA Class III, or ambul. NYHA Class IV, OPT, freq. dependence on vent. pacing", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "36"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "4"}]}]}, {"title": "Class IIb - EF \u2264 35%, NYHA Class I or II, OPT, device implant with anticipated frequent vent. pacing", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "36"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "5"}]}]}, {"title": "Replacement CRT-P device", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "36"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "6"}]}]}, {"title": "Other", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "36"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "2"}]}]}]}, {"title": "NYHA Class", "description": "New York Heart Association (NYHA) Classification places subjects into one of four categories based on their physical activity limitations with Class I = no limitations, Class II = Mild limitations, Class III = Moderate limitations and Class IV = Severe limitations.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "I", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "24"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "25"}]}]}, {"title": "II", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "18"}]}]}, {"title": "III", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "21"}, {"groupId": "BG002", "value": "23"}]}]}, {"title": "IV", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "3"}]}]}, {"title": "Not reported", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "64"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "67"}]}]}]}, {"title": "LVEF", "populationDescription": "Measure not reported for all subjects.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "percent", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "43"}, {"groupId": "BG001", "value": "33"}, {"groupId": "BG002", "value": "76"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "55.7", "spread": "10.5"}, {"groupId": "BG001", "value": "29.2", "spread": "8.4"}, {"groupId": "BG002", "value": "44.1", "spread": "16.3"}]}]}]}, {"title": "QRS Duration", "populationDescription": "Measure not reported for all subjects.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "ms", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "82"}, {"groupId": "BG001", "value": "32"}, {"groupId": "BG002", "value": "114"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "109", "spread": "33"}, {"groupId": "BG001", "value": "158", "spread": "24"}, {"groupId": "BG002", "value": "123", "spread": "38"}]}]}]}, {"title": "BMI", "populationDescription": "Measure not reported for all subjects.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kg/m^2", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "87"}, {"groupId": "BG001", "value": "33"}, {"groupId": "BG002", "value": "120"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "26.3", "spread": "4.1"}, {"groupId": "BG001", "value": "27.2", "spread": "4.0"}, {"groupId": "BG002", "value": "26.6", "spread": "4.1"}]}]}]}, {"title": "Body Surface Area", "populationDescription": "Measure not reported for all subjects.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "m^2", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "87"}, {"groupId": "BG001", "value": "33"}, {"groupId": "BG002", "value": "120"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "1.9", "spread": "0.3"}, {"groupId": "BG001", "value": "1.9", "spread": "0.2"}, {"groupId": "BG002", "value": "1.9", "spread": "0.2"}]}]}]}, {"title": "Concomitant Medications", "description": "Subjects may contribute to more than one category.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "ACE Inhibitor", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "27"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "45"}]}]}, {"title": "Angiotensin Receptor Blocker", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "16"}, {"groupId": "BG002", "value": "42"}]}]}, {"title": "Diuretics", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "27"}, {"groupId": "BG002", "value": "53"}]}]}, {"title": "Sodium Channel Blockers - Class I", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "3"}]}]}, {"title": "Beta Blockers - Class II", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "26"}, {"groupId": "BG002", "value": "52"}]}]}, {"title": "Potassium Channel Blockers - Class III", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "7"}]}]}, {"title": "Calcium Channel Blockers - Class IV", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "30"}]}]}, {"title": "Other Cardiovascular Medications", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "60"}, {"groupId": "BG001", "value": "29"}, {"groupId": "BG002", "value": "89"}]}]}]}, {"title": "Etiology", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "No Disease (age related)", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "80"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "84"}]}]}, {"title": "Ischemic Cardiomyopathy", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "17"}, {"groupId": "BG002", "value": "27"}]}]}, {"title": "Idiopathic Cardiomyopathy", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "15"}]}]}, {"title": "Valvular Cardiomyopathy", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "7"}]}]}, {"title": "Congenital Heart Disease", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "2"}]}]}, {"title": "Hypertrophic Cardiomyopathy", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}]}]}, {"title": "Atrial Arrhythmias", "description": "Subjects may contribute to more than one category", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Paroxysmal Atrial Fibrillation", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "18"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "26"}]}]}, {"title": "Atrial Tachycardia/Flutter", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "7"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "10"}]}]}, {"title": "Persistent Atrial Fibrillation", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}]}, {"title": "Other Supraventricular Tachycardia", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "3"}]}]}, {"title": "None", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "72"}, {"groupId": "BG001", "value": "26"}, {"groupId": "BG002", "value": "98"}]}]}]}, {"title": "Brady Arrhythmias:", "description": "Subjects may contribute to more than one category", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Sinus Node Dysfunction", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "32"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "33"}]}]}, {"title": "3rd Degree AV Block - Intermittent", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "21"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "24"}]}]}, {"title": "2nd Degree AV Block - Intermittent", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "19"}]}]}, {"title": "3rd Degree AV Block - Permanent", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "15"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "19"}]}]}, {"title": "1st Degree AV Block", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "18"}]}]}, {"title": "Bradycardia", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "16"}]}]}, {"title": "2nd Degree AV Block - Permanent", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "10"}]}]}, {"title": "Sinus Arrest", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "7"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "7"}]}]}, {"title": "Chronotropic Incompetence", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "5"}]}]}, {"title": "None", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "26"}]}]}]}, {"title": "Cardiac Disease & Arrhythmia HistorY", "description": "Subjects may contribute to more than one category", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Hypertension", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "64"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "76"}]}]}, {"title": "Diabetes", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "23"}, {"groupId": "BG001", "value": "11"}, {"groupId": "BG002", "value": "34"}]}]}, {"title": "Heart Failure", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "23"}, {"groupId": "BG002", "value": "29"}]}]}, {"title": "Chronic Pulmonary Disease", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "14"}]}]}, {"title": "Renal Disease", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "11"}]}]}, {"title": "Other", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "34"}]}]}, {"title": "None", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "100"}, {"groupId": "BG001", "value": "36"}, {"groupId": "BG002", "value": "136"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "25"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "29"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Accuracy of Commanded Right Atrial Automatic Threshold (RAAT)", "description": "Accuracy was evaluated by the proportion of tests resulting in an RAAT commanded threshold with \\|Manual unipolar threshold - commanded threshold\\| \u2264 0.5V. Subjects were allowed to contribute multiple paired datasets for this endpoint analysis, one set each from the 1-month and 3-month visits. Paired datasets from the 1-month and 3-month visits were pooled for purposes of endpoint analysis. A paired dataset consisted of the manual unipolar threshold and the commanded threshold obtained at a visit.", "populationDescription": "Arms/Groups are only applicable for the outcome measure 'Secondary Outcome: RYTHMIQ - Median Relative Reduction of RV Pacing Percent (RVPP) for RYTHMIQ Programmed to ON vs. RYTHMIQ Programmed to OFF'.\n\nThis outcome measure was analyzed only for the combined population. Analysis performed on subjects with paired datasets, each consisting of a commanded RAAT threshold and manual unipolar threshold collected at the 1- and 3-month visits.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of accurate RAAT tests", "timeFrame": "3 months post implant", "typeUnitsAnalyzed": "Paired threshold tests", "denomUnitsSelected": "Paired threshold tests", "groups": [{"id": "OG000", "title": "RAAT Commanded Threshold", "description": "Subjects with paired RAAT commanded threshold and manual unipolar threshold available"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "132"}]}, {"units": "Paired threshold tests", "counts": [{"groupId": "OG000", "value": "190"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "100", "lowerLimit": "96.8", "upperLimit": "100"}]}]}]}, {"type": "PRIMARY", "title": "System-related Complication-free Rate", "description": "Arms/Groups are only applicable for the outcome measure 'Secondary Outcome: RYTHMIQ - Median Relative Reduction of RV Pacing Percent (RVPP) for RYTHMIQ Programmed to ON vs. RYTHMIQ Programmed to OFF'.\n\nThis outcome measure was analyzed only for the combined population and both pacemakers and CRT-P devices were pooled for the analysis. The analysis assesses the system-related complication (SRC) -free rate (excluding LV related events for CRT-P subjects) for subjects implanted or attempted to be implanted with a study device through the first 90 days following the implant procedure.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of subjects free from SRC", "timeFrame": "90 days post-implant", "groups": [{"id": "OG000", "title": "Implanted or Attempted", "description": "All subjects, who were implanted with a study device or attempted to be implanted with a study device."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "136"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "87.5", "lowerLimit": "81.8", "upperLimit": "100"}]}]}]}, {"type": "SECONDARY", "title": "Accuracy of Ambulatory RAAT", "description": "Arms/Groups are only applicable for the outcome measure 'Secondary Outcome: RYTHMIQ - Median Relative Reduction of RV Pacing Percent (RVPP) for RYTHMIQ Programmed to ON vs. RYTHMIQ Programmed to OFF'.\n\nThis outcome measure was analyzed only for the combined population (pacemaker and CRT-P). Accuracy was evaluated by the proportion of tests resulting in an RAAT ambulatory threshold with \\|ambulatory threshold - commanded threshold\\| \u2264 1.0V. Subjects were allowed to contribute multiple paired datasets for this endpoint analysis, one set each from the 1-month and 3-month visits. Paired datasets from the 1-month and 3-month visits were pooled for purposes of endpoint analysis. A paired dataset consisted consisted of the ambulatory threshold obtained within 7 days prior to the visit and the commanded threshold obtained at the visit.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Paired threshold tests", "timeFrame": "3 months post-implant", "typeUnitsAnalyzed": "Paired threshold tests", "denomUnitsSelected": "Paired threshold tests", "groups": [{"id": "OG000", "title": "Implanted", "description": "All subjects, who were implanted with a study device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "132"}]}, {"units": "Paired threshold tests", "counts": [{"groupId": "OG000", "value": "187"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "186", "lowerLimit": "182", "upperLimit": "187"}]}]}]}, {"type": "SECONDARY", "title": "Appropriate RAAT Test Outcome", "description": "Arms/Groups are only applicable for the outcome measure 'Secondary Outcome: RYTHMIQ - Median Relative Reduction of RV Pacing Percent (RVPP) for RYTHMIQ Programmed to ON vs. RYTHMIQ Programmed to OFF'.\n\nThis outcome measure was analyzed only for the combined population (pacemaker and CRT-P). Accuracy was evaluated by the proportion of tests with an appropriate commanded RAAT test outcome. An appropriate RAAT outcome consists of either a device-determined threshold or a code indicating that a threshold could not be determined and representing a condition that is beyond the control of the RAAT feature and could occur as well in manual threshold test, such as atrial fibrillation.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of approprite RAAT tests", "timeFrame": "3 months post-implant", "typeUnitsAnalyzed": "threshold tests", "denomUnitsSelected": "threshold tests", "groups": [{"id": "OG000", "title": "Implanted", "description": "All subjects, who were implanted with a study device"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "132"}]}, {"units": "threshold tests", "counts": [{"groupId": "OG000", "value": "242"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "84.7", "lowerLimit": "80.4", "upperLimit": "100"}]}]}]}, {"type": "SECONDARY", "title": "RYTHMIQ - Median Relative Reduction of RV Pacing Percent (RVPP) for RYTHMIQ On at Pre-Discharge, Off at 1-Month vs. RYTHMIQ Off at Pre-discharge, On at 1-Month", "description": "Chronic success is assessed by a median relative reduction of RV pacing percent (RVPP) for RYTHMIQ On at Pre-Discharge, Off at 1-Month vs. RYTHMIQ On at Pre-Discharge, Off at 1-Month. All patients received both RYTHMIQ programmed to ON and programmed to OFF in two consecutive periods, where the patient's programming allocation was randomized for the first period. Then a crossover to the alternate setting occurred for the second period once the end of the first period was reached.", "populationDescription": "Pacemaker subjects with RYTHMIQ information available for both randomization periods.", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Full Range", "unitOfMeasure": "Percentage of RV pacing", "timeFrame": "3 months post implant", "groups": [{"id": "OG000", "title": "Pacemaker Subjects Without Permanent 3\u00b0 AV Block", "description": "Subjects receiving a pacemaker study device (implanted or attempted) except those with permanent 3\u00b0 AV Block"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "84"}]}], "classes": [{"title": "RYTHMIQ On", "categories": [{"measurements": [{"groupId": "OG000", "value": "4", "lowerLimit": "0", "upperLimit": "100"}]}]}, {"title": "RYTHMIQ Off", "categories": [{"measurements": [{"groupId": "OG000", "value": "98", "lowerLimit": "1", "upperLimit": "100"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of RAAT Threshold Tests With Sufficient RAAT Pace Output Margin", "description": "This outcome measure was analyzed only for the combined population (Pacemaker and CRT-P). The sufficient pacing output voltage that is able to capture the right atrium was evaluated by the proportion of Right Atrial Automatic Threshold (RAAT) tests with \\[RAAToutput \u2265 (max(BP,UP) + \u03b4 )\\] where BP refers to the manual bipolar threshold, UP refers to the manual unipolar threshold, and \u03b4 refers to the safety margin of 0.5V. Subjects were allowed to contribute multiple paired datasets for this endpoint analysis, one set each from the 1-month and 3-month visits. Paired datasets from the 1-month and 3-month visits were pooled for purposes of endpoint analysis. A paired dataset consisted of the commanded threshold and the maximum manual threshold (i.e. the maximum of the manual unipolar and manual bipolar thresholds) obtained at a visit.", "populationDescription": "Pooled subjects with a sufficient pacing output voltage to capture the right atrium at the 1-month and the 3-month follow-up visits.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of RAAT w. sufficient output", "timeFrame": "3 months post implant", "typeUnitsAnalyzed": "Right Atrial Automatic Threshold Tests", "denomUnitsSelected": "Right Atrial Automatic Threshold Tests", "groups": [{"id": "OG000", "title": "Pooled Pacemaker and CRT-P Population", "description": "All Pacemaker implanted subjects and all CRT-P implanted subjects."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "132"}]}, {"units": "Right Atrial Automatic Threshold Tests", "counts": [{"groupId": "OG000", "value": "195"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "100", "lowerLimit": "98.5", "upperLimit": "100"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "1 year", "eventGroups": [{"id": "EG000", "title": "Subjects Implanted With a Study Device or Attempted to be Implanted With a Study Device", "description": "The study's primary endpoints were designed to assess adverse events for all participants under one category of Cardiac Implantable Electronic Devices (CIED) safety as a unified group. Reporting thus reflects the collective safety profile of CIED interventions as planned and analyzed. This approach was consistent with the study's protocol and objectives, which did not include arm/group-specific AE analysis as a key outcome.", "deathsNumAffected": 5, "deathsNumAtRisk": 136, "seriousNumAffected": 52, "seriousNumAtRisk": 136, "otherNumAffected": 24, "otherNumAtRisk": 136}], "seriousEvents": [{"term": "PG - Oversensing - RV", "organSystem": "Product Issues", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "PG - Infection (> 30 days post-implant)", "organSystem": "Product Issues", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Procedure - Venous occlusion", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 136}]}, {"term": "Hematoma - Pocket (<=30 days post-implant)", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Renal failure due to contrast media - Procedure", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Venous occlusion", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Venous occlusion", "organSystem": "Product Issues", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "LV - difficult visualization", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Dislodgment - RA", "organSystem": "Product Issues", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 136}]}, {"term": "Dislodgment - RV", "organSystem": "Product Issues", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Extracardiac stimulation - LV", "organSystem": "Product Issues", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 36}]}, {"term": "Dyspnea - Heart failure", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 136}]}, {"term": "Heart failure symptoms - Unspecified", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 136}]}, {"term": "Multiple heart failure symptoms", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 136}]}, {"term": "Atrial Arrhythmias (Heart Failure related)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Pleural Effusion", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Atrial fibrillation (AF)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 136}]}, {"term": "Atrial flutter", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 136}]}, {"term": "Other SVT", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "AVRT, AVNRT, EAT etc.", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Peripheral vascular disease", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 136}]}, {"term": "Intermittent claudication", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Aortic regurgitation", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Syncope", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Dizziness", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Chest pain", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Cerebrovascular accident (CVA)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Pulmonary embolism", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Adverse Drug Effect", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Chest Pain", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Multiple symptoms", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Death", "organSystem": "Product Issues", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Death", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Systemic infection", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Physical trauma", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Hematological", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Neurological", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 136}]}, {"term": "Gastrointestinal", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 136}]}, {"term": "Pulmonary", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 2, "numAtRisk": 136}]}, {"term": "Genitourinary", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Renal", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 4, "numAtRisk": 136}]}, {"term": "Musculoskeletal", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 6, "numAtRisk": 136}]}, {"term": "Integumentary", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 136}]}, {"term": "Head, eyes, ears, nose, throat (HEENT)", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Immune", "organSystem": "Immune system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}, {"term": "Cancer", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 7, "numAtRisk": 136}]}, {"term": "Multi-system failure", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 136}]}], "otherEvents": [{"term": "Extracardiac stimulation - LV", "organSystem": "Product Issues", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Extracardiac stimulation - LV, only applicable to LV leads. CRT-P subjects have LV leads implanted, Pacemaker subjects do not have LV leads implanted.", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 11, "numAtRisk": 36}]}, {"term": "Atrial fibrillation (AF)", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 13, "numAtRisk": 136}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Consultant (PI) acknowledges and agrees that (i) Consultant shall not publish any data, report, white papers or other materials arising out of the Services performed pursuant to this Agreement without the prior written consent of Boston Scientific, and (ii) any such publication shall not include Boston Scientific Confidential Information except prior written consent of Boston Scientific."}, "pointOfContact": {"title": "Clinical Trial Manager", "organization": "Boston Scientific", "email": "jens.goetzke@bsci.com", "phone": "+18002273422"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000012804", "term": "Sick Sinus Syndrome"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000006327", "term": "Heart Block"}, {"id": "D000001145", "term": "Arrhythmias, Cardiac"}, {"id": "D000075224", "term": "Cardiac Conduction System Disease"}, {"id": "D000010335", "term": "Pathologic Processes"}, {"id": "D000001146", "term": "Arrhythmia, Sinus"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "relevance": "LOW"}, {"id": "M27765", "name": "Atrioventricular Block", "relevance": "LOW"}, {"id": "M16355", "name": "Syndrome", "relevance": "LOW"}, {"id": "M15610", "name": "Sick Sinus Syndrome", "asFound": "Sinus Node Disease", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M9415", "name": "Heart Block", "relevance": "LOW"}, {"id": "M4453", "name": "Arrhythmias, Cardiac", "relevance": "LOW"}, {"id": "M1472", "name": "Cardiac Conduction System Disease", "relevance": "LOW"}, {"id": "M4454", "name": "Arrhythmia, Sinus", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}]}}, "hasResults": true}